<?xml version="1.0" encoding="utf-8"?>
	<collection>
		
	
		<source>SourceData</source>
		
	
		<date>2019-04-19</date>
		
	
		<key>sourcedata.key</key>
		
	
		<document>
			
		
			<id>5048377 Figure_1-B</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 1-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B Dose response curves for viability of parental cells (in red) or selected clones (in black) upon treatment with NFR for 48h. The green dashed box highlight concentration in the physiologically relevant range. Curves are mean ± s.e.m. of 3 independent experiments performed in triplicate. P values were calculated using 2way ANOVA analysis of variance between parental cells and each individual clone. Bar graph represents the EC50 (half maximal effective concentration) of the dose responses. Data are mean ± s.e.m. of 3 independent experiments performed in triplicate. P values were calculated using 1way ANOVA analysis of variance (P value in red) followed by Dunnett's multiple comparison tests. *P value ≤ 0.05, ** P value ≤ 0.01.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_1-C</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 1-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C The parental population and the NFR resistant clones were analyzed for eEF2K mRNA expression by real-time PCR relative to β-actin (mean and s.e.m. from 3 independent batches of cells are shown). P values were calculated using 1way ANOVA analysis of variance followed by Dunnett's multiple comparison tests. *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:actin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="127"/>
					
				
					<text>actin</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_1-D</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 1-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D The parental population and representative NFR resistant clones were analyzed by WB for eFF2K total protein level. Tubulin is used as loading control. Histogram represents mean and s.e.m of relative eEF2K level quantified from WB of 4 different batches of cells collected at different dates (see also source data). P values were calculated using 1way ANOVA analysis of variance followed by Dunnett's multiple comparison tests. *** P value ≤ 0.001.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Tubulin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="7" offset="117"/>
					
				
					<text>Tubulin</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_2-A</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 2-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A Immunoblot analysis of eEF2 Thr56 phosphorylation (P-eEF2) in HeLa cells treated for 6h with increasing doses of NFR, and compared with 10 μg/ml tunicamycin (TM), 200 nM rapamycin (Rapa.) or 1h starvation (Starv.). Tubulin is used as loading control.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Tubulin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="7" offset="218"/>
					
				
					<text>Tubulin</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:Thr56</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="5" offset="30"/>
					
				
					<text>Thr56</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_2-B</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 2-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B eEF2K WT and KO MEF treated for 6h with indicated concentration of NFR, 200 nM rapamycin (Rapa.), 1h starvation (Starv.) or 1 mM of the AMPK activator AICAR, were analyzed by immunoblot with antibodies directed against total or phosphorylated eEF2 (Thr56).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_2-C</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 2-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C Three representative NFR-resistant HeLa clones were analyzed by Immunoblot for eEF2K expression level and eEF2 phosphorylation upon NFR and compared to parental HeLa cells. For treatments, medium was replaced for 6h with medium containing DMSO (Mock), increasing doses of NFR or 10 μg/ml tunicamycin (TM), or for 1h with PBS for starvation (Starv.). Tubulin is used as loading control.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Tubulin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="7" offset="353"/>
					
				
					<text>Tubulin</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:eEF2K</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="5" offset="81"/>
					
				
					<text>eEF2K</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_2-D</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 2-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D Immunoblot analysis of eEF2 Thr56 phosphorylation in HeLa cells treated for 6h with increasing doses of different HIV-PIs as indicated or the NFR metabolite M8 (hydroxy-tert-butylamide). Molecular structures of the different HIV-PIs used are indicated. Each panel is representative of at least 3 independent experiments.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Thr56</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="30"/>
					
				
					<text>Thr56</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_3-B</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 3-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B eEF2K WT and KO MEF treated for 6h with indicated concentration of NFR, Rapamycin (Rapa), AICAR or starved for indicated time in PBS (Starv.), were analyzed by immunoblot using indicated antibodies. Tubulin is used as loading control.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Tubulin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="7" offset="201"/>
					
				
					<text>Tubulin</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_3-C</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 3-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C A potent mTOR inhibition does not impair NFR-mediated eEF2 phosphorylation. WT MEFs were treated with the indicated concentrations of Rapamycin or with vehicle (Mock). After 30 minutes, indicated doses of NFR were added and cells were incubated for additional 6h and analyzed for phosphorylated S6R and eEF2. Tubulin is used as loading control.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Tubulin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="7" offset="311"/>
					
				
					<text>Tubulin</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:mTOR</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="4" offset="11"/>
					
				
					<text>mTOR</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_3-D</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 3-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D NFR-mediated eEF2 phosphorylation is not affected in AMPKα1α2 dKO. AMPKα1α2 WT and dKO MEF treated for 6h with indicated concentration of NFR, Rapamycin (Rapa), AICAR or starved for 1h in PBS (Starv.), were analyzed by immuoblot with indicated antibodies. * anti-total AMPKα antibody give an unspecific band with a slightly higher molecular weight in dKO cells. Tubulin is used as loading control. Each panel is representative of at least 3 independent experiments.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:AMPKα</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="6" offset="55"/>
					
				
					<text>AMPKα</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:AMPKα</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="6" offset="71"/>
					
				
					<text>AMPKα</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:AMPKα</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="6" offset="275"/>
					
				
					<text>AMPKα</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_4-A-B</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 4-A-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-B EEF2K contributes to the decreased translation observed with NFR without impacting translation in presence of TM. A. Quantification of newly synthesized proteins at 0, 2, 4 and 6h after 20 μM NFR (left panels) or 10 μg/ml TM (right panels) treatment in MEF eEF2K +/+ and eEF2K-/-. Treated cells were labeled for 15 minutes with 35S-methionine and visualized by SDS PAGE and subsequent autoradiography. Autoradiographies from four different experiments (see also source data) were quantified and results show percentage of translation compared to untreated cells. The mean and s.e.m of four independent metabolic labeling experiments are shown. *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001 obtained using 2way ANOVA analysis of variance (in red) followed by Bonferroni posttest (in black). B. eEF2K+/+, eEF2K-/-, eIF2αWT and eIF2αS51A MEFs were treated for 6h with indicated doses of NFR, 200 nM rapamycin, or 10 μg/ml TM, or for 30 min with 10 μg/ml CHX. 35S-methionine incorporation was measured by liquid scintillation counting. Data are shown as the percentage of translation compared to untreated cells. *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001 obtained using 2way ANOVA analysis of variance followed by Bonferroni posttest.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:posttest</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="8" offset="791"/>
					
				
					<text>posttest</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:posttest</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="8" offset="1267"/>
					
				
					<text>posttest</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_4-C</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 4-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C Representative polysome profiles of eEF2K WT and KO MEF treated 6h with NFR or TM. Area under curve for Sub-polysomes (S) and Polysomes (P) used to calculate the P/S ratio were indicated (see also raw data provided). Bar graph represents ratio normalized to untreated cells. OD254 nm is optical density at 254 nm. Data showed mean ±s.e.m. of P/S ratio calculated from 3 independent experiments. P values were calculated using 1way ANOVA analysis of variance followed by Bonferroni posttest; *P value ≤ 0.05, ** P value ≤ 0.01.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_4-D</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 4-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D The ribosome half-transit time in MEFs eEF2K+/+ and eEF2K-/- was determined as described in Materials and Methods. Incorporation of 35S-Methionine into total protein within the PMS and PRS was obtained by linear regression analysis. Presented graphs are representative of two (CHX 1 μg/ml for 30 min and Starvation 30 min in PBS in eEF2K+/+ cells) to four (NFR 20μM for 6h in eEF2K+/+ and eEF2K-/- cells) independent experiments. Indicated values represent the x displacement measurement (in time) between the PMS line at 300sec and the PRS line (see also raw data provided). Histogram represents mean and s.e.m. of the ribosome half transit time from four independent experiments. P values were calculated using two tails unpaired Student's T-tests; *P value ≤ 0.05.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_5-A</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 5-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A MEF eEF2K WT, KO or KO reconstituted with human eEF2K (Flag-eEF2K) were analyzed for cell growth at indicated times. Fold change (means ± s.e.m of triplicate) of the cell number just before treatment are shown. Histogram shows percentage of growth inhibition after 72h of 10 μM NFR. P values are 1way ANOVA with Bonferroni posttest calculated from 3 independent experiments. *** P value ≤ 0.001.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="57"/>
					
				
					<text>Flag</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_5-B-C</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 5-B-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B-F Dose response curves for cell viability after 48h NFR measured using MTS assay. Curves and bar graph for EC50 are mean ± s.e.m. of 3 independent experiments performed in triplicate. For curves, p values are 2way ANOVA analysis of variance. For bar graph, p values are two tails unpaired Student's T-tests (B, E), or 1way ANOVA with Bonferroni (C) or Dunnett's multiple comparison posttests (D and F). *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001. (B,C) eEF2K -/- MEFs show a decrease susceptibly to NFR compared to eEF2K +/+ controls (B) whereas eEF2K reconstitution restores NFR sensitivity (C).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Bonferroni</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="10" offset="337"/>
					
				
					<text>Bonferroni</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_5-D-E-F</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 5-D-E-F</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-D-E-F</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B-F Dose response curves for cell viability after 48h NFR measured using MTS assay. Curves and bar graph for EC50 are mean ± s.e.m. of 3 independent experiments performed in triplicate. For curves, p values are 2way ANOVA analysis of variance. For bar graph, p values are two tails unpaired Student's T-tests (B, E), or 1way ANOVA with Bonferroni (C) or Dunnett's multiple comparison posttests (D and F). *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001. (D-F), HeLa (D), A549 (E) and MCF7 (F) clones with CRISPR-Cas9 generated eEF2K deficiency (CrEEF2K) show a decrease susceptibly to NFR compare to control cells (CrLuci).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Bonferroni</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="10" offset="337"/>
					
				
					<text>Bonferroni</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:CRISPR</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="6" offset="520"/>
					
				
					<text>CRISPR</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_5-G</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 5-G</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-G</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>G NFR-mediated toxicity assessed using AnnexinV/PI staining and FACS analysis after 24h treatment. Histogram shows the percentage of dead cells (AV+/PI+). Data are mean ± s.e.m. of 3 independent experiments. P values are 2way ANOVA with Bonferroni posttest. *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_6-A</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 6-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A Tumor volumes of eEF2K -/- and eEF2K +/+ RasV12 engraft implanted subcutaneously in AGR129mice. Treatment with NFR or vehicle was initiated 6 days post-implantation. Data are mean of tumor volume ± s.e.m. (n = 8 per group). P values were calculated using 2way ANOVA followed by Bonferroni posttest comparing WT tumor with vehicle or NFR treatment and KO tumors with vehicle or NFR treatment; *P value ≤ 0.05, ** P value ≤ 0.01, *** P value ≤ 0.001. Experiment is representative of 2 performed in same conditions.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:tumor</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="185"/>
					
				
					<text>tumor</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:tumor</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="5" offset="314"/>
					
				
					<text>tumor</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:tumor</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="5" offset="357"/>
					
				
					<text>tumor</text>
					
			
				</annotation>
				
			
				<annotation id="4">
					
				
					<infon key="type">protein:Ras</infon>
					
				
					<infon key="sourcedata_figure_annot_id">4</infon>
					
				
					<infon key="sourcedata_article_annot_id">4</infon>
					
				
					<location length="3" offset="43"/>
					
				
					<text>Ras</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5048377 Figure_6-B-C</id>
			
		
			<infon key="sourcedata_document">2236</infon>
			
		
			<infon key="doi">10.15252/embr.201642194</infon>
			
		
			<infon key="pmc_id">5048377</infon>
			
		
			<infon key="figure">Figure 6-B-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B Immunoblots for total and phosphorylated eEF2 of tumor engraftment from (A). (NS, Non-Specific signal.) C Bar graph shows relative phosphorylation intensities of eEF2 compared with total eEF2 determined by densitometry analysis. Mean ± s.e.m. are shown (n=4). P values were calculated using 2way ANOVA followed by Bonferroni posttest ; **P value ≤ 0.01.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:tumor</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="51"/>
					
				
					<text>tumor</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		

	</collection>
